Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I
Jay L Bock1, Adam J Singer, Henry C Thode
1Department of Pathology, Stony Brook University, Stony Brook, NY 11794-7300, USA.
Insights
Rapid point-of-care whole blood cardiac troponin I testing generally aligns with central laboratory plasma assays for acute coronary syndrome. However, it may miss minor elevations and produce some false positives.
Area of Science:
- Clinical diagnostics
- Cardiovascular medicine
- Biomarker analysis
Background:
- Acute coronary syndrome (ACS) diagnosis relies on cardiac troponin I (cTnI) levels.
- Point-of-care testing (POCT) offers rapid results but requires validation against central laboratory assays.
Purpose of the Study:
- To compare the diagnostic performance of a rapid, whole blood POCT assay for cTnI against a central laboratory plasma assay.
- To evaluate the reliability of POCT for patient classification in emergency department settings.
Main Methods:
- Prospective comparison of Abbott i-STAT whole blood cTnI (Tn-P) with Siemens TnI-Ultra plasma assay (Tn-U) in emergency department patients with suspected ACS.
- Retesting of elevated Tn-P results and a random selection of negative Tn-P results using Tn-U.
Main Results:
- Of 5,909 initial Tn-P tests, 573 (9.7%) were elevated. Of these, 4.5% retested negative by Tn-U.
- The Tn-U assay generally yielded higher results (approx. 50%) and had a lower 99th percentile cutoff than Tn-P.
- 5.8% of initially negative Tn-P results retested as elevated by Tn-U, with low levels (<0.1 ng/mL).
Conclusions:
- Rapid whole blood cTnI POCT provides generally reliable patient classification compared to central laboratory plasma assays.
- The POCT assay may miss subtle elevations in cTnI and can produce false positives, necessitating careful interpretation.
Abstract:
For patients admitted to the emergency department (ED) with suspected acute coronary syndrome, we compared results of a rapid, point-of-care whole blood assay for cardiac troponin I (Abbott i-STAT, Abbott Point-of-Care, East Windsor, NJ) (Tn-P) with an automated central laboratory plasma assay (Siemens TnI-Ultra, Siemens Medical Solutions Diagnostics, Tarrytown, NY) (Tn-U). Clinical data were obtained during a 6-month period during which ED patients were screened by Tn-P, with retesting of elevated results by Tn-U. Of 5,909 Tn-P results, 573 (9.7%) were elevated; these and a random selection of 137 negative specimens were retested by Tn-U. Of the specimens with elevated results, 4.5% retested negative by Tn-U, even though Tn-U typically gave about 50% higher results and had a lower manufacturer-specified 99th percentile cutoff. Of the negatives, 5.8% retested as elevated by Tn-U, but with levels no higher than 0.1 ng/mL (0.1 microg/L). Rapid whole blood testing for cardiac troponin I gave generally reliable patient classifications compared with plasma testing in the central laboratory, but besides missing small elevations, produced some apparent false-positives.
More Related Videos
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
